Purification of HLA Immunopeptidomes from Human Thymus
Reference9 articles.
1. Malcherek G, Falk K, Rotzschke O, Rammensee HG, Stevanovic S, Gnau V, Jung G, Melms A (1993) Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int Immunol 5(10):1229–1237. https://doi.org/10.1093/intimm/5.10.1229 2. Fleischhauer K, Avila D, Vilbois F, Traversari C, Bordignon C, Wallny HJ (1994) Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. Tissue Antigens 44(5):311–317. https://doi.org/10.1111/j.1399-0039.1994.tb02401.x 3. Urban RG, Chicz RM, Lane WS, Strominger JL, Rehm A, Kenter MJ, UytdeHaag FG, Ploegh H, Uchanska-Ziegler B, Ziegler A (1994) A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc Natl Acad Sci U S A 91(4):1534–1538. https://doi.org/10.1073/pnas.91.4.1534 4. Paradela A, Alvarez I, Garcia-Peydro M, Sesma L, Ramos M, Vazquez J, Lopez De Castro JA (2000) Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway. J Immunol 164(1):329–337. https://doi.org/10.4049/jimmunol.164.1.329 5. Alvarez I, Collado JA, Colobran R, Carrascal M, Ciudad MT, Canals F, James EA, Kwok WW, Gartner M, Kyewski B, Pujol-Borrell R, Jaraquemada D (2015) Central T cell tolerance: identification of tissue-restricted autoantigens in the thymus HLA-DR peptidome. J Autoimmun 60:12–19. https://doi.org/10.1016/j.jaut.2015.03.004
|
|